Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.

Kikutake C, Yahara K.

PLoS One. 2016 Apr 4;11(4):e0152918. doi: 10.1371/journal.pone.0152918. eCollection 2016.

2.

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.

Suzuki A, Makinoshima H, Wakaguri H, Esumi H, Sugano S, Kohno T, Tsuchihara K, Suzuki Y.

Nucleic Acids Res. 2014 Dec 16;42(22):13557-72. doi: 10.1093/nar/gku885. Epub 2014 Nov 6.

3.

Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.

Ramnath N, Nadal E, Jeon CK, Sandoval J, Colacino J, Rozek LS, Christensen PJ, Esteller M, Beer DG, Kim SH.

J Thorac Oncol. 2014 Apr;9(4):473-82. doi: 10.1097/JTO.0000000000000114.

4.

Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.

Zhang QH, Dai XH, Dai ZM, Cai YN.

Genet Mol Res. 2015 Aug 7;14(3):9200-14. doi: 10.4238/2015.August.7.30.

6.

Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.

Lu Y, Liu Y, Liao S, Tu W, Shen Y, Yan Y, Tao D, Lu Y, Ma Y, Yang Y, Zhang S.

Oncotarget. 2016 Jul 12;7(28):43162-43176. doi: 10.18632/oncotarget.9012.

7.

Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.

Lenka G, Tsai MH, Lin HC, Hsiao JH, Lee YC, Lu TP, Lee JM, Hsu CP, Lai LC, Chuang EY.

Sci Rep. 2017 Feb 15;7:42573. doi: 10.1038/srep42573.

8.
9.

Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.

Müller I, Wischnewski F, Pantel K, Schwarzenbach H.

BMC Cancer. 2010 Jun 17;10:297. doi: 10.1186/1471-2407-10-297.

10.

Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.

Tessema M, Yingling CM, Liu Y, Tellez CS, Van Neste L, Baylin SS, Belinsky SA.

Carcinogenesis. 2014 Jun;35(6):1248-57. doi: 10.1093/carcin/bgt494. Epub 2014 Jan 7.

11.

Histone modifications for human epigenome analysis.

Kimura H.

J Hum Genet. 2013 Jul;58(7):439-45. doi: 10.1038/jhg.2013.66. Epub 2013 Jun 6. Review.

PMID:
23739122
12.

Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes.

Liu H, Liu X, Zhang S, Lv J, Li S, Shang S, Jia S, Wei Y, Wang F, Su J, Wu Q, Zhang Y.

Nucleic Acids Res. 2016 Jan 8;44(1):75-94. doi: 10.1093/nar/gkv1332. Epub 2015 Dec 3.

13.

Characterization of the human thyroid epigenome.

Siu C, Wiseman S, Gakkhar S, Heravi-Moussavi A, Bilenky M, Carles A, Sierocinski T, Tam A, Zhao E, Kasaian K, Moore RA, Mungall AJ, Walker B, Thomson T, Marra MA, Hirst M, Jones SJM.

J Endocrinol. 2017 Nov;235(2):153-165. doi: 10.1530/JOE-17-0145. Epub 2017 Aug 14.

PMID:
28808080
14.

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, Lam S, Gazdar AF, Laird-Offringa IA.

Genome Res. 2012 Jul;22(7):1197-211. doi: 10.1101/gr.132662.111. Epub 2012 May 21.

15.

Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa.

Enroth S, Rada-Iglesisas A, Andersson R, Wallerman O, Wanders A, Påhlman L, Komorowski J, Wadelius C.

BMC Cancer. 2011 Oct 19;11:450. doi: 10.1186/1471-2407-11-450.

16.

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

Yang Q, Tian Y, Ostler KR, Chlenski A, Guerrero LJ, Salwen HR, Godley LA, Cohn SL.

BMC Cancer. 2010 Jun 14;10:286. doi: 10.1186/1471-2407-10-286.

17.

Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.

Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, Sekido Y.

Cancer Res. 2009 Dec 1;69(23):9073-82. doi: 10.1158/0008-5472.CAN-09-1595. Epub 2009 Nov 3.

18.

Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.

Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H.

Cytotherapy. 2013 Sep;15(9):1164-73. doi: 10.1016/j.jcyt.2013.05.001. Epub 2013 Jun 22.

PMID:
23800731
19.

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.

Dudziec E, Gogol-Döring A, Cookson V, Chen W, Catto J.

PLoS One. 2012;7(3):e32750. doi: 10.1371/journal.pone.0032750. Epub 2012 Mar 7.

20.

Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.

Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Øyan AM, Kalland KH.

BMC Genomics. 2010 Nov 25;11:669. doi: 10.1186/1471-2164-11-669.

Supplemental Content

Support Center